Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Multiple Ascending Doses of Nafithromycin in Healthy Volunteers
NCT03979859Phase 1Completed
- Sponsor
- Wockhardt
- Start
- Aug 2013
- Primary completion
- Dec 2013
- Modality
- RNA-Targeting Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in community-acquired bacterial pneumonia (CAP) comparing WCK 4873 with Placebo (2 arms). Primary endpoints: Incidence of Treatment Emergent Adverse Events at Day 24, Area Under Curve at Day 10 and 2 more. Started Aug 2013; status: completed.
02
Drugs
nafithromycin
03
Conditions
community-acquired bacterial pneumonia (CAP)
Beyond the preview
Go deeper on NCT03979859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03979859.